Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Medicago Announces Phase 3 Study of VLP Quadrivalent Influenza Vaccine

americanpharmaceuticacreviewSeptember 27, 2017

Tag: Medicago , VLP Quadrivalent , influenza vaccine

PharmaSources Customer Service